{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:01:22Z","timestamp":1791907282060,"version":"4.3.4"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"995","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Thyroid hormone resistance (THR) is a rare syndrome of reduced end organ sensitivity. Patients with THR have elevated serum free thyroxine (FT4), free triiodothyronine (FT3), but normal or slightly elevated serum thyrotropin values. The characteristic clinical feature is goitre without symptoms and metabolic consequences of thyroid hormone excess. THR can be classified on the basis of tissue resistance into pituitary, peripheral or generalised (both pituitary and peripheral) types. Mutations in the TR\u03b2 gene, cell membrane transporter and genes controlling intracellular metabolism of thyroid hormone have been implicated. THR is differentiated from thyroid stimulating hormone (TSH) secreting pituitary adenoma by history of THR in the family. No specific treatment is often required for THR; patients with features of hypo- or hyperthyroidism are appropriately treated with levo-triiodothyronine (L-T3), levo-thyroxine (L-T4), dextro-thyroxine(D-T4) or 3,3,5 triiodo-thyroacetic acid (TRIAC). The diagnosis helps in appropriate genetic counselling of the family.<\/jats:p>","DOI":"10.1136\/pgmj.2008.069740","type":"journal-article","created":{"date-parts":[[2008,10,21]],"date-time":"2008-10-21T17:13:04Z","timestamp":1224609184000},"page":"473-477","source":"Crossref","is-referenced-by-count":46,"title":["Thyroid hormone resistance"],"prefix":"10.1093","volume":"84","author":[{"given":"N K","family":"Agrawal","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Institute of Medical Sciences, Banaras Hindu University , Varanasi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Goyal","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Institute of Medical Sciences, Banaras Hindu University , Varanasi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Rastogi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Institute of Medical Sciences, Banaras Hindu University , Varanasi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Naik","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Institute of Medical Sciences, Banaras Hindu University , Varanasi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S K","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Institute of Medical Sciences, Banaras Hindu University , Varanasi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,10,21]]},"reference":[{"key":"2023041909544143500_bib1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1210\/jcem-27-2-279","article-title":"De Groot LJ. Familial syndrome combining deaf-mutism, stippled epiphyses, goitre and abnormally high PBI: possible target organ refractoriness to thyroid hormone","volume":"27","author":"Refetoff","year":"1967","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041909544143500_bib2","first-page":"348","article-title":"The syndromes of resistance of thyroid hormone","volume":"14","author":"Refetoff","year":"1993","journal-title":"Endocr Rev"},{"key":"2023041909544143500_bib3","first-page":"1109","volume-title":"Werner and Ingbar's The thyroid: a fundamental and clinical text","author":"Refetoff","year":"2005","edition":"9th ed"},{"key":"2023041909544143500_bib4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/thy.1994.4.225","article-title":"The variable clinical phenotype in thyroid hormone resistance syndrome","volume":"4","author":"Beck-Peccoz","year":"1994","journal-title":"Thyroid"},{"key":"2023041909544143500_bib5","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/0002-9343(81)90885-8","article-title":"Partial peripheral resistance thyroid hormone","volume":"70","author":"Kaplan","year":"1981","journal-title":"Am J Med"},{"key":"2023041909544143500_bib6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.beem.2007.03.005","article-title":"Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination","volume":"21","author":"Refetoff","year":"2007","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"2023041909544143500_bib7","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1210\/mend-2-12-1217","article-title":"Tight linkage between thyroid hormone resistance and the human c-erbA\u03b2 gene","volume":"2","author":"Usala","year":"1988","journal-title":"Mol Endocrinol"},{"key":"2023041909544143500_bib8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1258\/000456306778904678","article-title":"Thyroid hormone resistance","volume":"43","author":"Olateju","year":"2006","journal-title":"Ann Clin Biochem"},{"key":"2023041909544143500_bib9","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1172\/JCI117362","article-title":"Genetic analysis of twenty-nine kindreds with generalized and pituitary resistance to thyroid hormone","volume":"94","author":"Adams","year":"1994","journal-title":"J Clin Invest"},{"key":"2023041909544143500_bib10","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1210\/jc.2006-0727","article-title":"Mosaicism of a thyroid hormone receptor gene mutation in resistance to thyroid hormone","volume":"91","author":"Mamanasiri","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041909544143500_bib11","first-page":"4196","article-title":"Dominant inheritance of resistance to thyroid hormone not linked to defects in the thyroid hormone receptor \u03b1 or \u03b2 genes may be due to a defective cofactor","volume":"81","author":"Weiss","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041909544143500_bib12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00060793-200010000-00008","article-title":"Resistance to thyroid hormone in the absence of mutations in the thyroid hormone receptor genes","volume":"7","author":"Sadow","year":"2000","journal-title":"Curr Opin Endocrinol Diabetes"},{"key":"2023041909544143500_bib13","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/ng1654","article-title":"Mutations in SECISBP2 result in abnormal thyroid hormone metabolism","volume":"37","author":"Dumitrescu","year":"2005","journal-title":"Nat Genet"},{"key":"2023041909544143500_bib14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1086\/380999","article-title":"A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene","volume":"74","author":"Dumitrescu","year":"2004","journal-title":"Am J Human Genet"},{"key":"2023041909544143500_bib15","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(04)17226-7","article-title":"Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation","volume":"364","author":"Friesema","year":"2004","journal-title":"Lancet"},{"key":"2023041909544143500_bib16","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/emboj\/18.7.1900","article-title":"Mice deficient in the steroid receptor coactivator I (SRC-1) are resistant to thyroid hormone","volume":"18","author":"Weiss","year":"1999","journal-title":"EMBO J"},{"key":"2023041909544143500_bib17","first-page":"1262","article-title":"Spectrum of transcriptional dimerization and dominant negative properties of twenty different mutant thyroid \u03b2 receptors in thyroid hormone resistance syndrome","volume":"8","author":"Collingwood","year":"1994","journal-title":"Mol Endocrinol"},{"key":"2023041909544143500_bib18","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1210\/jcem-73-5-990","article-title":"Homozygosity for a dominant negative thyroid hormone","volume":"73","author":"Ono","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041909544143500_bib19","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1210\/mend.11.4.9914","article-title":"Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors","volume":"11","author":"Yoh","year":"1997","journal-title":"Mol Endocrinol"},{"key":"2023041909544143500_bib20","doi-asserted-by":"crossref","first-page":"572","DOI":"10.7326\/0003-4819-123-8-199510150-00002","article-title":"Genetic and clinical features of 42 kindreds with resistance to thyroid hormone","volume":"123","author":"Brucker","year":"1995","journal-title":"Ann Intern Med"},{"key":"2023041909544143500_bib21","first-page":"1034","article-title":"Evidence for the secretion of thyrotropin with enhanced bioactivity in syndromes of thyroid hormone resistance","volume":"78","author":"Persani","year":"1974","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041909544143500_bib22","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJM199304083281403","article-title":"Attention deficit-hyperactivity disorder in people with generalized resistance of thyroid hormone","volume":"328","author":"Hauser","year":"1993","journal-title":"N Engl J Med"},{"key":"2023041909544143500_bib23","first-page":"1039","article-title":"Correlation of language abnormalities with localization of mutations in the \u03b2-thyroid hormone receptor in 13 kindreds with generalized resistance to thyroid hormone: identification of four new mutations","volume":"75","author":"Mixson","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041909544143500_bib24","first-page":"2768","article-title":"Prevalence and mechanism of hearing loss in patients with resistance to thyroid hormone","volume":"81","author":"Brucker-Davis","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041909544143500_bib25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0950-351X(05)80252-6","article-title":"The variable clinical phenotype in thyroid hormone resistance syndrome","volume":"8","author":"Chatterjee","year":"1994","journal-title":"Ballieres Clin Endocrinol Metab"},{"key":"2023041909544143500_bib26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF03350611","article-title":"Successful treatment of hyperthyroidism due to nonneoplastic pituitary TSH hypersecretion with 3,5,3-triiodothyroacetic acid (TRIAC)","volume":"6","author":"Beck-Peccoz","year":"1983","journal-title":"J Endocrinol Invest"},{"key":"2023041909544143500_bib27","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1089\/thy.1997.7.775","article-title":"Clinical and hormonal outcome after two years of TRIAC treatment in a child with thyroid hormone resistance","volume":"7","author":"Radetti","year":"1997","journal-title":"Thyroid"},{"key":"2023041909544143500_bib28","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/thy.1996.6.563","article-title":"Differences in response of thyrotropin to 3,5,3\u2032-triiodothyronine and 3,5,3\u2032-triiodothyroacetic acid in patients with resistance to thyroid hormone","volume":"6","author":"Ueda","year":"1996","journal-title":"Thyroid"},{"key":"2023041909544143500_bib29","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1210\/jcem-67-5-1089","article-title":"Hyperthyroidism due to selective pituitary resistance to thyroid hormones in 15-month-old boy: efficacy of D-thyroxine therapy","volume":"67","author":"Hamon","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041909544143500_bib30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2265.1990.tb00858.x","article-title":"Thyrotoxicosis due to pituitary resistance to thyroid hormones. Successful control with D-thyroxine: a study in 3 patients","volume":"32","author":"Dorey","year":"1990","journal-title":"Clin Endocrinol"},{"key":"2023041909544143500_bib31","first-page":"1071","article-title":"Bromocriptine and TRIAC therapy for hyperthyroidism due to pituitary resistance to thyroid hormone","volume":"75","author":"Dulgeroff","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041909544143500_bib32","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1210\/jcem-68-1-208","article-title":"Treatment of hyperthyroidism due to inappropriate secretion of thyrotropin with the somatostatin analog SMS 201\u2013995","volume":"68","author":"Beck-Peccoz","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041909544143500_bib33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/105072504322783876","article-title":"Regression of large goiter in a patient with resistance to thyroid hormone by every other day treatment with triiodothyronine","volume":"14","author":"Anselmo","year":"2004","journal-title":"Thyroid"},{"key":"2023041909544143500_bib34","first-page":"401","article-title":"Treatment of resistance to thyroid hormone \u2013 primum non nocere","volume":"84","author":"Weiss","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041909544143500_bib35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1043-2760(02)00043-7","article-title":"Thyroid hormone receptors: lessons from knock-out and knock-in mutant mice","volume":"14","author":"Flamant","year":"2003","journal-title":"Trends Endocrinol Metab"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/84\/995\/473\/50021684\/postgradmedj-84-473.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/84\/995\/473\/50021684\/postgradmedj-84-473.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T09:57:22Z","timestamp":1681898242000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/84\/995\/473\/7026342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,1]]},"references-count":35,"journal-issue":{"issue":"995","published-online":{"date-parts":[[2008,10,21]]},"published-print":{"date-parts":[[2008,9,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.2008.069740","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2008,9]]},"published":{"date-parts":[[2008,9,1]]}}}